Good evening :)
Switch to
Place Order

Aarti Drugs Ltd

AARTIDRUGS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,644 cr, stock is ranked 456
Moderate RiskStock is 2.33x as volatile as Nifty
609.556.10 (-0.99%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,644 cr, stock is ranked 456
Moderate RiskStock is 2.33x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
20.13
PB RatioPB Ratio
6.18
Dividend YieldDiv. Yield
0.41%
Sector PESector PE
38.41
Sector PBSector PB
5.12
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aarti Drugs Limited is a pharmaceutical company offering active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.

Investor PresentationView older 

Jul 28, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

20182019202020211.241.571.812.160.080.090.140.28
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnOct 13, 2021

Aarti Drugs Limited has informed the Exchange about Loss of Share Certificates | Download

Aarti Drugs Limited has informed the Exchange about Loss of Share Certificates | Download

Appointment 
Announced OnOct 13, 2021

Aarti Drugs Limited has informed the Exchange regarding Appointment of Mr Ankit Vikram Paleja as Non- Executive Independent Director of the company w.e.f. October 13, 2021. | Download

Aarti Drugs Limited has informed the Exchange regarding Appointment of Mr Ankit Vikram Paleja as Non- Executive Independent Director of the company w.e.f. October 13, 2021. | Download

Cash Dividend 
Ex. DateNov 3, 2020

Interim • Div/Share: ₹ 2.5

See all events